Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1946 10
1947 14
1948 8
1949 13
1950 21
1951 29
1952 24
1953 25
1954 24
1955 27
1956 28
1957 21
1958 21
1959 35
1960 22
1961 24
1962 23
1963 26
1964 30
1965 13
1966 1
1967 1
1969 1
1971 1
1972 5
1973 83
1974 396
1975 533
1976 466
1977 424
1978 418
1979 494
1980 446
1981 548
1982 477
1983 510
1984 500
1985 543
1986 578
1987 479
1988 478
1989 519
1990 557
1991 596
1992 583
1993 532
1994 531
1995 494
1996 538
1997 498
1998 524
1999 571
2000 605
2001 735
2002 840
2003 998
2004 1300
2005 1643
2006 1882
2007 2164
2008 2304
2009 2424
2010 2971
2011 3342
2012 3459
2013 3611
2014 3642
2015 3491
2016 3251
2017 3047
2018 2801
2019 2608
2020 2472
2021 2073
2022 1832
2023 1522
2024 2256
2025 1527
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65,001 results

Results by year

Filters applied: . Clear all
Page 1
PEGylation technology: addressing concerns, moving forward.
Simberg D, Barenholz Y, Roffler SR, Landfester K, Kabanov AV, Moghimi SM. Simberg D, et al. Drug Deliv. 2025 Dec;32(1):2494775. doi: 10.1080/10717544.2025.2494775. Epub 2025 Apr 23. Drug Deliv. 2025. PMID: 40264371 Free PMC article. Review.
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform.
Zhang Y, Li Z, Ritter J, Brea EJ, Mahadevan NR, Dillon DA, Park SR, Liu EM, Tolstorukov MY, McGourty WE, Lizotte P, Ivanova EV, Fahey C, Haratani K, Thai TC, Soroko KM, Kivlehan S, Smith EL, Gokhale PC, Paweletz CP, Barbie DA, Barbie TU. Zhang Y, et al. Cell Rep Med. 2025 Jul 15;6(7):102198. doi: 10.1016/j.xcrm.2025.102198. Epub 2025 Jun 20. Cell Rep Med. 2025. PMID: 40543510 Free PMC article.
Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.
Khoury R, Longobardi G, Barnatan TT, Venkert D, García Alvarado A, Yona A, Green Buzhor M, Shahar S, Wang Q, Acúrcio RC, Guedes RC, Florindo HF, Zhao JJ, Satchi-Fainaro R. Khoury R, et al. J Control Release. 2025 Jul 10;383:113812. doi: 10.1016/j.jconrel.2025.113812. Epub 2025 May 2. J Control Release. 2025. PMID: 40319918 Free article.
65,001 results
You have reached the last available page of results. Please see the User Guide for more information.